BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 19571750)

  • 1. Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.
    Platt D; Griggs R
    Curr Opin Neurol; 2009 Oct; 22(5):524-31. PubMed ID: 19571750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle channelopathies.
    Saperstein DS
    Semin Neurol; 2008 Apr; 28(2):260-9. PubMed ID: 18351527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.
    Raja Rayan DL; Hanna MG
    Curr Opin Neurol; 2010 Oct; 23(5):466-76. PubMed ID: 20634695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.
    Statland JM; Barohn RJ
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1598-614. PubMed ID: 24305449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle channelopathies.
    Statland J; Phillips L; Trivedi JR
    Neurol Clin; 2014 Aug; 32(3):801-15, x. PubMed ID: 25037091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal Muscle Channelopathies.
    Vivekanandam V; Munot P; Hanna MG; Matthews E
    Neurol Clin; 2020 Aug; 38(3):481-491. PubMed ID: 32703462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
    Ryan AM; Matthews E; Hanna MG
    Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence study of genetically defined skeletal muscle channelopathies in England.
    Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
    Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into the pathomechanisms of skeletal muscle channelopathies.
    Burge JA; Hanna MG
    Curr Neurol Neurosci Rep; 2012 Feb; 12(1):62-9. PubMed ID: 22083238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle Channelopathies.
    Trivedi JR
    Continuum (Minneap Minn); 2022 Dec; 28(6):1778-1799. PubMed ID: 36537980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle channelopathies: recent advances in genetics, pathophysiology and therapy.
    Suetterlin K; Männikkö R; Hanna MG
    Curr Opin Neurol; 2014 Oct; 27(5):583-90. PubMed ID: 25188014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Channelopathies: the nondystrophic myotonias and periodic paralyses.
    Lehmann-Horn F; Rüdel R
    Semin Pediatr Neurol; 1996 Jun; 3(2):122-39. PubMed ID: 8795846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nondystrophic myotonias.
    Heatwole CR; Moxley RT
    Neurotherapeutics; 2007 Apr; 4(2):238-51. PubMed ID: 17395134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuromuscular hereditary channelopathies: non-dystrophic myotonias, paramyotonias and periodic paralysis].
    Ruggieri VL; Arberas CL
    Rev Neurol; 2002 Jan 16-31; 34(2):150-6. PubMed ID: 11988910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodic paralysis.
    Fialho D; Griggs RC; Matthews E
    Handb Clin Neurol; 2018; 148():505-520. PubMed ID: 29478596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscle channelopathies. Myotonias and periodic paralyses].
    Jurkat-Rott K; Lerche H; Lehmann-Horn F
    Nervenarzt; 2011 Apr; 82(4):511-20; quiz 521. PubMed ID: 21484581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing in skeletal muscle ion channelopathies.
    Altamura C; Saltarella I; Campanale C; Laghetti P; Desaphy JF
    Curr Opin Pharmacol; 2023 Feb; 68():102329. PubMed ID: 36512979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle channelopathies: a guide to diagnosis and management.
    Matthews E; Holmes S; Fialho D
    Pract Neurol; 2021 Jun; 21(3):196-204. PubMed ID: 33563766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of neuromuscular channelopathies: current concepts and future prospects.
    Cleland JC; Griggs RC
    Neurotherapeutics; 2008 Oct; 5(4):607-12. PubMed ID: 19019313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.